Oncopeptides AB (publ)

Oncopeptides AB (publ)verified

ONCO.ST

Price:

$2.075

Market Cap:

$438.37M

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.[Read more]

Industry

Biotechnology

IPO Date

2017-02-22

Stock Exchange

STO

Ticker

ONCO.ST

The Current Ratio as of November 2024 (TTM) for Oncopeptides AB (publ) (ONCO.ST) is 3.48

According to Oncopeptides AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 3.48. This represents a change of -18.53% compared to the average of 4.27 of the last 4 quarters.

Oncopeptides AB (publ) (ONCO.ST) Historical Current Ratio (quarterly & annually)

How has ONCO.ST Current Ratio performed in the past?

The mean historical Current Ratio of Oncopeptides AB (publ) over the last ten years is 3.56. The current 3.48 Current Ratio has changed 9.66% with respect to the historical average. Over the past ten years (40 quarters), ONCO.ST's Current Ratio was at its highest in in the March 2017 quarter at 13.75. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

3.56

Median

3.20

Minimum

0.60

Maximum

7.95

Oncopeptides AB (publ) (ONCO.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Oncopeptides AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 329.41%

Maximum Annual Current Ratio = 7.95

Minimum Annual Increase = -74.25%

Minimum Annual Current Ratio = 0.60

Quarterly (TTM)
Annual
YearCurrent RatioChange
20234.526.27%
20224.25132.14%
20211.83-27.50%
20202.52-57.04%
20195.8851.62%
20183.88-51.27%
20177.95329.41%
20161.85206.57%
20150.60-74.25%

Oncopeptides AB (publ) (ONCO.ST) Average Current Ratio

How has ONCO.ST Current Ratio performed in the past?

The current Current Ratio of Oncopeptides AB (publ) (ONCO.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.53

5-year avg

3.80

10-year avg

3.56

Oncopeptides AB (publ) (ONCO.ST) Current Ratio vs. Peers

How is ONCO.ST’s Current Ratio compared to its peers?

Oncopeptides AB (publ)’s Current Ratio is greater than Hansa Biopharma AB (publ) (2.45), less than BioArctic AB (publ) (7.18), greater than Calliditas Therapeutics AB (publ) (2.69), greater than Sinch AB (publ) (0.58), less than Cantargia AB (publ) (3.67),

Build a custom stock screener for Oncopeptides AB (publ) (ONCO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncopeptides AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncopeptides AB (publ) (ONCO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncopeptides AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Oncopeptides AB (publ)'s Current Ratio?

How is the Current Ratio calculated for Oncopeptides AB (publ) (ONCO.ST)?

What is the highest Current Ratio for Oncopeptides AB (publ) (ONCO.ST)?

What is the 3-year average Current Ratio for Oncopeptides AB (publ) (ONCO.ST)?

What is the 5-year average Current Ratio for Oncopeptides AB (publ) (ONCO.ST)?

How does the current Current Ratio for Oncopeptides AB (publ) (ONCO.ST) compare to its historical average?